Skip to main content

Table 1 Summary of immunohistochemical findings derived from leiomyoadenomatoid tumors, as reported in the literature

From: Leiomyoadenomatoid tumor of uterus: two case reports with literature review

Cases

Age

Site

Immunohistochemical findings

Current case (first)

38

Uterine body

CK7 (+), CK20 (−), calretinin (+), WT1 (+), D2–40 (+), CD31 (−), CD34(−), ERG (−), CDX-2 (−), PAX8 (−), SMA (+)

Current case (second)

26

Uterine body

AE1/AE3 (+), calretinin (+), WT1 (+), D2–40 (+), KI67 (low proliferative index), SMA (+)

Amre R et al. (2)

52

Uterine body

Pan-CK (+)

Mathew M et al. (3)

51

Uterine body

Not performed

Bedir R et al. (4)

51

Uterine body

Pan-CK (+), CK7 (+), CK19 (+), CK20 (−), calretinin (+), HBME-1 (+), SMA (+)a, CD31 (−), CD34 (−), CEA (−), EMA (−),ER (−), PR (−), GCDF-15 (−), KI67 (low proliferative index)

Ersavaş S et al. (5)

30

Uterine body

CK7 (+), EMA (+), HMBE-1 (+), calretinin (+), PR (+), CK20 (−), Actin (−), Caldesmon (−), CD34 (−), CD31 (−), FVIIIRA (−), D2–40 (−), CEA (−),SMA (+)a

Sarma N et al. (7)

45

Uterine body

Calretinin (+), vimentin (−), SMA (+)a, KI67 (low proliferative index)

Bahuguna G et al. (8)

65

Uterine body (multicentric)

Calretinin (+), CEA (−), CD34 (−), KI67 (low proliferative index)

Dobrosz Z et al. (9)

57

Uterine body

CK7 (+), CK20 (−), HBME-1 (+), calretinin (+), CD31 (−), CD34 (−), CEA (−), actin (+)a, SMA (+)a, vimentin (+)a, desmin(+)a, KI67 (low proliferative index)

Junainah EM et al. (10)

45

Uterine body and the fallopian tubes (multicentric)

AE1/AE3 (+), EMA (+), CAM 5.2 (+), CK5/6 (+ focal), CD31 (−), CD34 (−), SMA (+)a, caldesmon (+)a, KI67 (low proliferative index)

Prangsgaard T et al. (11)

24

Uterine body

KL1(+), calretinin (+), HBME-1 (+), CK7/8 (+), vimentin (+),CD31(−), CD34(−), SMA(+)a, desmin (+)a, KI67 (low proliferative index)

Amérigo J et al. (12)

55

Uterine body

AE1/AE3 (+), CK7 (+), CK20 (−),HBME-1 (+), calretinin (+), vimentin (+), CEA (−), FVIIIRA (−), CD31 (−), CD34 (−), CD117 (−)

Erra S et al. (13)

44

Uterine serosa

Pan-CK (+), CK5/6 (+), calretinin (+), HBME-1 (+), vimentin (+), SMA (+)a, CEA (−), GCDF-15 (−), E-cadherin (−), CD31 (−), CD34 (−),

Kopuz A et al. (14)

32

Uterine body

Pan-CK (+), calretinin (+), D2–40 (+), CD31 (−), CEA (−), KI67 (low proliferative index)

Hong R et al. (15)

24

Uterine body and ovary (multicentric)

CK7 (+), CK20 (−), calretinin (+), desmin (+)a, SMA (+)a, CEA (−), vimentin (−)

Ranjan R et al. (14)b

32–43

Uterine body

CK(+), WT1 (+), ER (−), SMA (+)a, CD34 (+)a, calretinin (+)

  1. Abbreviations: CD Cluster of differentiation, CEA Carcinoembryonic antigen, CK Cytokeratin, EMA Epithelial membrane antigen, ER Estrogen receptor, ERG Transcriptional regulator ERG related gene, FVIIIRA Factor VIII-related antigen, GCDF-15 gross cystic disease fluid protein-15, HBME-1 Hector Battifora mesothelial-1, PAX8 paired box gene 8, PR Progesterone receptor, SMA Smooth muscle actin, WT1 Wilms’ tumor 1
  2. a In smooth muscle component
  3. b Three cases